Nature Study Maps Immune Responses to Pig Kidney Xenotransplantation

New hopes and unknown challenges in xenotransplantation

Facing the global organ shortage crisis, gene-edited pig organs are seen as a ray of hope for saving lives. However, even after gene editing, strong immune rejection after cross-species transplantation remains a major obstacle leading to transplant failure. Historically, there have been numerous gaps in our understanding of how the human body specifically responds to pig organs. Recently, a blockbuster study published in the top journal "Nature" used multi-omics analysis technology for the first time to describe in detail and dynamically the complete immune process within 61 days of transplanting a pig kidney into a brain-dead recipient, outlining a detailed "immune response roadmap."

Xenotransplantation Immune Rejection Trilogy

By analyzing hundreds of thousands of data from blood and transplanted kidneys, the research team found that immune rejection is not a single event, but an orderly, multi-stage process:

Phase 1: B cell and antibody-mediated rejection (10-28 days after surgery)

The number of plasmablasts, NK cells, and dendritic cells in the blood increased significantly, and a large-scale expansion of B cell clones of IgG and IgA types was observed, which directly led to the antibody-mediated rejection confirmed by biopsy on the 33rd postoperative day.

The second stage: T cells join the battlefield (21-49 days after surgery)

On the basis of antibody rejection, human T cells began to increase on day 21 and peaked in blood and transplanted kidneys on days 33 to 49. T cell receptors became diversified and a specific dominant clonal type emerged (TRBV2/J1). Biopsy confirmed antibody- and T-cell-mediated mixed rejection on day 49.

Stage Three: Inflammation “Storm” and Tissue Damage

On day 33, the predominant human immune cells in the transplanted kidney were CXCL9+ macrophages, which drove a strong IFN-γ inflammatory response. The study also observed for the first time signs of interaction between the pig's own macrophages and infiltrating human immune cells. As early as days 21 to 33, profibrotic tubular and interstitial damage appeared in the kidney tissue, indicating that the transplanted kidney had begun to be damaged.

This historical image is currently unavailable.Open original image

Therapeutic Implications and Future Directions

Proteomic analysis confirmed that the complement system of both humans and pigs is activated during the rejection process, and after treatment with complement inhibitors, human complement activity significantly decreased, which provides clear targets and effective efficacy verification for clinical intervention. In addition, this study also accurately identified key immune cells and related molecular pathways such as specific T cell clones and CXCL9+ macrophages, pointing the way for the future development of more precise immunosuppressive programs or combination therapies. Although the experiment was completed in brain-dead recipients, and its findings cannot be directly equivalent to living donor transplantation, it provides an indispensable molecular basis and theoretical basis for advancing xenotransplantation into clinical practice, and is a key step towards solving the problem of organ shortage. In the future, it is hoped that more advanced omics technologies will be used to evaluate the changes in human immune response profiles after xenograft pig kidney transplantation, such as Olink proteome or antibody panel detection technology, which can detect immune response signals after transplantation with higher throughput and more sensitivity.